Moreover, they show how RSPRY1 deficiency disrupts ECM remodeling, cell motility, and cellular signaling processes, ultimately contributing to the SEMD phenotype. The gene discussed is RSPRY1; the disease is spondyloepimetaphyseal dysplasia.